**SBC Medical Group Holdings Inc. Reports Fiscal Year 2025 Results**
SBC Medical Group Holdings Inc., a management services provider for aesthetic clinics, reported total revenues of $173.6 million for the fiscal year ended December 31, 2025, a decrease of 15.5% compared to $205.4 million in 2024. The company attributed the revenue decline primarily to a revision in its fee structure for franchisee clinics, effective April 1, 2025, and a decrease in management services revenue. Net income for the year was $51.0 million, an increase of 9.3% compared to $46.7 million in the previous year. Cash flow from operating activities increased to $24.7 million from $20.6 million in the prior year.
The company's franchising revenue decreased by 24.7% to $45.9 million, while management services revenue declined by 44.2% to $29.6 million. Procurement revenue, however, increased slightly by 2.3% to $56.1 million, and rental services revenue rose by 42.7% to $23.0 million. Operating expenses decreased by 30.3% to $59.8 million, mainly due to a decrease in impairment loss on intangible assets and a decrease in stock-based compensation. The company also reported a gain on redemption of life insurance policies of $8.7 million, contributing to an increase in other income.
Strategic developments during the year included the acquisition of MB career lounge Co., Ltd. in July 2025 for $14.2 million and a controlling interest in Waqoo, Inc. in December 2025. The company also made a strategic minority equity investment of $20 million in OT Midco Holdings, LLC, holding an indirect minority interest in OrangeTwist, LLC. These acquisitions and investments are aimed at expanding the company's presence in the medical aesthetics market, both domestically and internationally.
As of December 31, 2025, SBC Medical Group Holdings Inc. provided management services to 237 franchisee treatment centers in Japan and operated 21 treatment centers in Singapore through Aesthetic Healthcare Holdings. The company also owned and operated one treatment center in Vietnam. The company's expansion strategy includes pursuing new clinic development, delivering consistent comparable franchisee clinic sales growth, increasing profitability, heightening brand awareness, and expanding through a multi-brand strategy. The company's common stock was added to the Russell 3000® Index on June 30, 2025.
About SBC Medical Group Holdings Inc
SBC Medical Group is a management company specializing in operating and supporting cosmetic treatment centers globally. It provides franchise management, marketing, staff recruitment, training, medical supplies, and licensing of proprietary technologies. Its core markets include Japan, Vietnam, Singapore, and the U.S., with a focus on high-quality aesthetic medical services. The company leverages advanced technology, brand licensing, and comprehensive operational support to differentiate in the cosmetic healthcare industry.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.